[1] |
Krieger EV, Valente AM. Diagnosis and management of ebstein anomaly of the tricuspid valve[J]. Curr Treat Options Cardiovasc Med, 2012, 14(6):594-607. doi: 10.1007/s11936-012-0209-2.
pmid: 23001420
|
[2] |
Kanoh M, Inai K, Shinohara T, et al. Influence of pregnancy on cardiac function and hemodynamics in women with Ebstein′s anomaly[J]. Acta Obstet Gynecol Scand, 2018, 97(8):1025-1031. doi: 10.1111/aogs.13373.
|
[3] |
Lima FV, Koutrolou-Sotiropoulou P, Yen TY, et al. Clinical characteristics and outcomes in pregnant women with Ebstein anomaly at the time of delivery in the USA: 2003-2012[J]. Arch Cardiovasc Dis, 2016, 109(6/7):390-398. doi: 10.1016/j.acvd.2016.01.010.
|
[4] |
Connolly HM, Warnes CA. Ebstein′s anomaly: outcome of pregnancy[J]. J Am Coll Cardiol, 1994, 23(5):1194-1198. doi: 10.1016/0735-1097(94)90610-6.
pmid: 8144788
|
[5] |
Schiebler GL, Gravenstein JS, Van Mierop LH. Ebstein′s anomaly of the tricuspid valve. Translation of original description with comments[J]. Am J Cardiol, 1968, 22(6):867-873. doi: 10.1016/0002-9149(68)90185-9.
pmid: 4880232
|
[6] |
Chopra S, Suri V, Aggarwal N, et al. Ebstein′s anomaly in pregnancy: maternal and neonatal outcomes[J]. J Obstet Gynaecol Res, 2010, 36(2):278-283. doi: 10.1111/j.1447-0756.2009.01130.x.
|
[7] |
Bardhi E, Faralli I, Deroma M, et al. Non-compaction cardiomyopathy in pregnancy: a case report of spongy myocardium in both mother and foetus and systematic review of literature[J]. J Matern Fetal Neonatal Med, 2021, 34(17):2910-2917. doi: 10.1080/14767058.2019.1671337.
|
[8] |
Drenthen W, Pieper PG, Roos-Hesselink JW, et al. Outcome of pregnancy in women with congenital heart disease: a literature review[J]. J Am Coll Cardiol, 2007, 49(24):2303-2311. doi: 10.1016/j.jacc.2007.03.027.
pmid: 17572244
|
[9] |
Paranon S, Acar P. Ebstein′s anomaly of the tricuspid valve: from fetus to adult: congenital heart disease[J]. Heart, 2008, 94(2):237-243. doi: 10.1136/hrt.2006.105262.
pmid: 18195130
|
[10] |
Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC)[J]. Eur Heart J, 2011, 32(24):3147-3197. doi: 10.1093/eurheartj/ehr218.
pmid: 21873418
|
[11] |
林建华. 国内外妊娠合并心血管疾病的指南和专家共识解读[J]. 实用妇产科杂志, 2020, 36(8):588-590.
|
[12] |
Baumgartner H, De Backer J, Babu-Narayan SV, et al. 2020 ESC Guidelines for the management of adult congenital heart disease[J]. Eur Heart J, 2021, 42(6):563-645. doi: 10.1093/eurheartj/ehaa554.
pmid: 32860028
|
[13] |
Donnelly JE, Brown JM, Radford DJ. Pregnancy outcome and Ebstein′s anomaly[J]. Br Heart J, 1991, 66(5):368-371. doi: 10.1136/hrt.66.5.368.
pmid: 1747297
|
[14] |
Sharma N, Lalnunnem TJ, Nandwani M, et al. Ebstein Anomaly with Pregnancy: A Rare Case[J]. J Reprod Infertil, 2018, 19(2):119-122.
pmid: 30009147
|
[15] |
van der Zande JA, Tutarel O, Ramlakhan KP, et al. Pregnancy outcomes in women with Ebstein′s anomaly: data from the Registry of Pregnancy And Cardiac disease (ROPAC)[J]. Open Heart, 2023, 10(2):e002406. doi: 10.1136/openhrt-2023-002406.
|
[16] |
Ruys TP, Roos-Hesselink JW, Pijuan-Domènech A, et al. Is a planned caesarean section in women with cardiac disease beneficial?[J]. Heart, 2015, 101(7):530-536. doi: 10.1136/heartjnl-2014-306497.
pmid: 25539946
|